Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Item No. 39151

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
8-Methoxymethyl-3-isobutyl-1-methylxanthine is an inhibitor of phosphodiesterase 1 (PDE1; IC50 = 5 µM) and a derivative of IBMX (Item No. 13347).1 It is selective for PDE1 over PDE2, PDE3, and PDE4 but also inhibits PDE5 (IC50s = 37, >400, >400, and 2 µM, respectively). 8-Methoxymethyl-3-isobutyl-1-methylxanthine (30 µM) enhances forskolin-induced increases in intracellular calcium levels in isolated rat olfactory receptor neurons.2 It induces relaxation of isolated human saphenous vein segments in the absence of endothelium (EC50 = 31 µM).3 In vivo, 8-methoxymethyl-3-isobutyl-1-methylxanthine (200 µg/kg) enhances decreases in pulmonary artery pressure and vascular resistance induced by iloprost (Item No. 18215) in a rabbit model of pulmonary hypertension induced by the TP receptor agonist U-46619 (Item No. 16450).4
WARNING This product is not for human or veterinary use.
1. Cyclic AMP-
2. Characterization of forskolin-
3. The flavonoid dioclein is a selective inhibitor of cyclic nucleotide phosphodiesterase type 1 (PDE1) and a cGMP-
4. Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: Amplification by different type phosphodiesterase inhibitors. Respir. Res. 6(1), 76 (2005).